Alterations in carbohydrate metabolism in HIV/AIDS patients;Alteraciones del metabolismo hidrocarbonado en el paciente VIH/SIDA

Nutricion Hospitalaria

Volumn 17, Issue 3, 2002, Pages 147-153

  Gomez Candela C ^a   De Cos Blanco, A I ^a   Mateo, R ^a   Castro, E ^a   Lorenzo, A ^a   Polo, R ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Diabetes; Diet; Drugs; HIV AIDS; Hyperglycaemia

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; COTRIMOXAZOLE; INSULIN; MEGESTROL; METFORMIN; ORAL ANTIDIABETIC AGENT; PENTAMIDINE; PROTEINASE INHIBITOR; REPAGLINIDE; SULFONYLUREA DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALGORITHM; BODY MASS; CARBOHYDRATE METABOLISM; EXERCISE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; LIFE EXPECTANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INSULIN RESISTANCE; LIPODYSTROPHY; METFORMIN; PREVALENCE; RISK FACTORS; THIAZOLES; THIAZOLIDINEDIONES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036316596     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Human obesity and thinness, hiperlipidemia, hiperglycemia, and insulin resistance associated with HIV1 protease inhibitors. Prevention by alternating several antiproteases in short sequences
2. Treatment with protease inhibitors associated with peripheral resistance and impaired oral glucosa tolerance in HIV 1-infected patients
3. Protease inhibitor associated hyperinsulinaemia
4. Alteraciones endocrinometabólicas en pacientes VIH positivos
5. Involvement of the pancreas in AIDS: A prespective study of 109 post-mortems
6. Alterations in glucose metabolism in noonendocrine disease: Potential implication for wasting
7. Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human inmunodeficiency virus (HIV)
8. Protease inhibitor associated hyperglycaemia
9. Grinspoon. Fasting hyperinsulinemia and changes in regional body y composition in human inmunodeficiency virus-infected women
10. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
11. Assesment of insulin sensitivity in vivo
12. A simple measure of insulin resistance
13. Pruebas diagnósticas para detectar la lipodistrofia
14. Glucosa clamp tecnique: A method for quantifying insulin secretion and resistance
15. Clasificación de las alteraciones morfológicas y metabólicas secundarias al tratamiento antirretroviral
16. ndReport of the expert panel on detection, evaluation and treatment of highblood cholesterol in adults
17. The mechasim or insulin resistance caused by HIV protease inhibitor therapy
18. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection
19. Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease
20. Asyndrome of peripheral fat wasting (lipodysistrophy) in patients receiving long-term nucleaside anologue therapy
21. Fat distribution evaluated in patients undergoing antiretroviral therapy: Preliminary results of the Lipoco study
22. Efectos secundarios del tratamiento antirretroviral: Cambios en el reparto de la grasa y alteraciones metabólicas. Introducción
23. Lipodystriohy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort
24. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: Correlation between dyslipidaemia and steroid hormonal alterations
25. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associaated lipodystrophy, hyperlipidaemia and diabetes mellitus: A cohort study
26. Hipoglycemia and diabetes mellitus following parenteral pentamidine mesylate treatment in AIDS patients
27. Diabetes mellitus associated with recombinant human growth hormone for HIV wasting syndrome
28. Phose I/II close escaletion and randomized withdrawal study with add-on azodicarbonmide in patients failing an current antiretrovirel therapy
29. Protocolo de tratamiento dietético en paciente diabético
30. Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice
31. Disorders of glucose metabilism in patients infected with human inmunodeficiency virus
32. Effect of troglitazone on insulen sensitivity in HIV-infected patrients with protease inhibitor-associated diabetes mellitus
33. Weight gain, improvement in metabilic prodile, and cD y count with insulin administration in as AIDS patient